Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
1.
J Clin Ultrasound ; 52(3): 338-340, 2024.
Article in English | MEDLINE | ID: mdl-38155537

ABSTRACT

A middle-aged woman presented to our hospital with a chief complaint of a mass on the left shoulder for 1 year. The initial lump was small with no pain or tenderness, and the patient had not sought medical attention for numbness in the left shoulder. Clinical examination showed a mass on the left shoulder measuring 11 × 8 × 3 cm approximately with no apparent skin damage or ecchymosis. No limitations in left shoulder joint movements were observed, and the patient exhibited normal movement of the left elbow joint, wrist joint, and metacarpophalangeal joint. Moreover, the left radial artery was palpable.


Subject(s)
Giant Cell Tumors , Shoulder , Middle Aged , Female , Humans , Giant Cell Tumors/diagnostic imaging , Giant Cell Tumors/pathology , Ultrasonography , Wrist Joint , Tendons/diagnostic imaging
2.
J Orthop Case Rep ; 13(11): 33-36, 2023 Nov.
Article in English | MEDLINE | ID: mdl-38025375

ABSTRACT

Introduction: Giant cell tumor of tendon sheath (GCTTS), also known as tenosynovial giant cell tumor or pigmented villonodular tenosynovitis, is a rare benign soft-tissue tumor with an unclear cause. It is the second most frequent soft-tissue tumor in the hand after ganglion cyst. Case Report: We described a female patient, age 19, who has had a 3 cm × 2 cm firm swelling on the palmer aspect of the right second metacarpal region for 7 years. The bulge developed spontaneously and moved quite slowly. It is required to do a histological and radiographic evaluation to determine whether or not to pursue additional treatment. Excision surgery was done, and the tumor was entirely removed. According to histopathology, this mass was compatible with GCTTS without being malignant. Conclusion: It is an uncommon instance of GCTTS at the hand, to sum up. The tumor should be entirely excised due to its high risk of recurrence to lower the likelihood of recurrence and restore hand function.

3.
J Orthop Case Rep ; 13(8): 32-35, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37654743

ABSTRACT

Introduction: Giant cell tumors of tendon sheath are benign, rarely malignant, soft-tissue tumors arising from tenosynovial sheath and periarticular soft tissue. They usually present as painless masses with some restriction of movement. Histopathological diagnosis is gold standard although pre-operative fine-needle aspiration cytology (FNAC), plain radiographs, and MRI help in narrowing down the differentials. Giant cell tumor of the tendon sheath (GCTTS) although benign is notorious for having a high rate of recurrences, with most important risk factors being adjacency to joint and incomplete excision. Adequate marginal excision forms the mainstay for managing these tumors. Adjuvant radiotherapy has found some role in treating and decreasing the chances of recurrences. Case Report: A 55-year-old lady was brought to the outpatient department with a history of painless, gradually progressive swelling on volar aspect of thumb. Swelling was well defined with a smooth surface. Overlying skin showed no signs of local inflammation or adherence. Pain radiographs showed soft-tissue shadow with some articular bony erosions. A ultrasound-guided FNAC and MRI showed a picture of GCTTS. An excisional biopsy was done and confirmed the diagnosis. Conclusion: GCTTS is a benign entity with a slow course of evolution, although uncommon, and should be kept as differential for swellings of hand and feet. Complete excision with no evidence residual tumor is diagnostic as well as curative. A regular follow-up is essential on account of high rates of recurrences.

5.
Cureus ; 15(4): e37600, 2023 Apr.
Article in English | MEDLINE | ID: mdl-37197098

ABSTRACT

A giant cell tumor of the tendon sheath (GCTTS) is a rare benign tumor that typically presents as a solitary mass in the hand or wrist. Multifocal presentation of GCTTS is extremely rare and has been reported in only a few cases. Although the origin of multifocal giant cell tumors of the tendon sheath remains incompletely elucidated, it is a rare disorder that distinguishes itself from the diffuse form of GCTTS that typically occurs near major joints. In this case study, we report a patient with a localized multifocal GCTTS affecting the tendon sheath of the flexor pollicis longus (FPL) on the volar surface of the right thumb. The diagnosis was confirmed by both radiological and histological examinations. Additionally, the patient underwent surgical excision of the tumor masses and did not encounter any recurrence during the six-month follow-up period.

6.
Skeletal Radiol ; 52(3): 593-603, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36063189

ABSTRACT

OBJECTIVE: To compare the MRI findings between the localized- and diffuse-type tenosynovial giant cell tumors (TSGCTs) of digits with pathology correlation. METHODS: Twenty-eight patients with newly diagnosed TSGCTs of digits (22 localized and 6 diffuse types) who underwent preoperative MRI and surgical excision were included from Jan. 2015 to September 2021. MRI findings regarding nodularity, margins, morphology of hypointensity with pathology correlation, and disease extent (bone erosion, articular involvement, muscle involvement, tendon destruction, and neurovascular encasement) were assessed. RESULTS: Diffuse type was significantly larger (P = 0.006), more multinodular on both MRI and pathology (P = 0.038, both) with significant agreement, and infiltrative on both MRI and pathology (P < 0.001, both) with substantial agreement, and showed central granular on MRI and strong hemosiderin deposition on pathology (P = 0.022 and P = 0.021) with moderate agreement than localized type. Localized type showed significantly more frequent peripheral capsules on both MRI and pathology (P < 0.001, both) with moderate agreement than diffuse type. However, the septum on both MRI and pathology showed no statistically significant difference between the two groups (P = 0.529 and P = 0.372) without significant agreement. The disease extent was more severe in the diffuse type than the localized type regarding articular involvement (P < 0.001), muscle involvement (P < 0.001), and tendon destruction (P = 0.010). No statistically significant differences were found between the two groups regarding bone erosion (P = 0.196) or neurovascular bundle encasement (P = 0.165). CONCLUSIONS: Diffuse-type TSGCTs of digits presented as locally aggressive lesions with larger, multinodular, infiltrative masses exhibiting stronger hemosiderin deposition and more severe disease extents of articular, muscle, and tendon involvement than the localized type.


Subject(s)
Giant Cell Tumor of Tendon Sheath , Giant Cell Tumors , Humans , Hemosiderin , Giant Cell Tumor of Tendon Sheath/diagnostic imaging , Tendons/diagnostic imaging , Tendons/pathology , Magnetic Resonance Imaging , Extremities/pathology , Giant Cell Tumors/diagnostic imaging
7.
Front Oncol ; 12: 878635, 2022.
Article in English | MEDLINE | ID: mdl-35814458

ABSTRACT

Giant cell tumor of tendon sheath (GCTTS) is a benign tumor. It occurs predominantly in the hands, ankles, and knees. A 39-year-old female presented with GCTTS in the right breast after breast augmentation. There was a clear borderline between the tumor and breast tissue. In terms of morphological appearance, synovial metaplasia could be observed in part of the collagenous capsule. The tumor was moderately cellular and was composed of synovium-like monocytes. The main part of the tumor was blended with nested and scattered xanthomatous cells, lymphocytes, and osteoclast-like giant cells. Hemosiderin granules were distributed in the lesion. Immunohistochemical staining and fluorescence in situ hybridization (FISH) analyses were performed. CD68 staining was positive in osteoclast-like giant cells. In addition, neither significant USP6 translocation nor CSF1 translocation was detected by FISH. We hypothesized that the pathogenesis of this rare GCT-TS was based on synovial metaplasia and did not depend on the translocation of classical CSF1.

8.
Mol Imaging Radionucl Ther ; 31(2): 145-147, 2022 Jun 27.
Article in English | MEDLINE | ID: mdl-35771035

ABSTRACT

A 77-year-old woman with follicular thyroid cancer underwent total thyroidectomy and subsequent Iodine-131 remnant ablation. She had a history of a wide tenosynovial giant cell tumor (TGCT) of the right wrist and hand that had been resected thirteen years ago. Post-therapeutic scintigraphy and single photon emission computed tomography showed mild uptake on the distal right forearm, wrist and hand. Magnetic resonance imaging and posterior histopathology confirmed a relapse of TGCT. No radioiodine adverse effects were reported after a one-year follow-up. As far as we know, this report is the first in the literature to a TGCT visualized on post-therapy radioiodine scan.

9.
Oncologist ; 27(2): 144-148, 2022 03 04.
Article in English | MEDLINE | ID: mdl-35641201

ABSTRACT

INTRODUCTION: Histiocytic disorders pose significant diagnostic and management challenges for the clinicians due to diverse clinical manifestations and often non-specific histopathologic findings. Herein, we report the tumor board experience from the first-of-its-kind Histiocytosis Working Group (HWG). MATERIALS AND METHODS: The HWG was established in June 2017 and consists of experts from 10 subspecialties that discuss cases in a multidisciplinary format. We present the outcome of tumor board case discussions during the first 2 years since its inception (June 2017-June 2019). RESULTS: Forty cases with a suspected histiocytic disorder were reviewed at HWG during this time period. Average number of subspecialties involved in HWG case discussion was 5 (range, 2-9). Histiocytosis Working Group tumor board recommendations led to significant changes in the care of 24 (60%) patients. These included change in diagnosis (n = 11, 27%) and change in treatment (n = 13, 33%). CONCLUSION: Our report highlights the feasibility of a multidisciplinary tumor board and its impact on outcomes of patients with histiocytic disorders.


Subject(s)
Histiocytosis , Neoplasms , Histiocytosis/diagnosis , Histiocytosis/pathology , Histiocytosis/therapy , Humans
10.
Onco Targets Ther ; 15: 53-66, 2022.
Article in English | MEDLINE | ID: mdl-35046667

ABSTRACT

Tenosynovial giant cell tumor (TGCT) is a neoplasm of the joint synovium that can have severe impacts on joint mobility, function, and quality of life. Traditionally, treatment modalities included partial or complete surgical synovectomy, radiotherapy (typically as an adjunct to surgery), and watchful monitoring (no medical or surgical intervention). However, these approaches have been met with varying degrees of success and high recurrence rates, as well as onerous complications and clinical sequelae. Pexidartinib, a colony-stimulating factor 1 receptor (CSF1R) inhibitor, presents a promising molecular approach that targets a neoplastic driver of TGCT. While the introduction of pexidartinib allows clinicians to avoid the significant morbidity associated with traditional treatment options, there are also defined risks associated with pexidartinib treatment. Therefore, patient selection is critical in optimizing treatment modalities in TGCT. The purpose of this literature review is to identify the TGCT patient population that would derive maximal benefit with minimal risk from pexidartinib, and to determine the specific indications and contraindications for selecting pexidartinib over other therapeutic approaches. Specifically, this paper compares the efficacy and safety profile of pexidartinib across clinical and preclinical studies to that of surgery, radiotherapy, and watchful monitoring. Rates of improvement in joint mobility, pain, and recurrence-free survival across studies of pexidartinib have been encouraging. The most common adverse events are mild (hypopigmentation of the hair) or reversible (transient aminotransferase elevation). Severe or permanent adverse events (notably cholestatic hepatotoxicity) are rare. While the optimal treatment strategy remains highly dependent on a patient's clinical circumstances and treatment goals, pexidartinib has surfaced as a promising therapeutic in cases where the morbidity of surgery or radiotherapy outweighs the benefits.

11.
J Orthop Case Rep ; 12(11): 83-86, 2022 Nov.
Article in English | MEDLINE | ID: mdl-37013224

ABSTRACT

Introduction: Giant cell tumors of tendon sheath (GCTTS) are benign soft-tissue lesions commonly affecting the digits, which occasionally cause pressure atrophy of an adjoining bone; but perforating the cortex to expand into the medullary canal is quite uncommon. We report such a case of suspected recurrent ganglion cyst with eventually manifested as a GCTTS with an intra-osseous involvement of the capitate and hamate bone. Case Presentation: A 28-year-old lady had been diagnosed as a case of recurrent ganglion cyst of the dorsum of the left wrist - 6 years ago and 4 years ago - both of which were confirmed histopathologically and were surgically excised. The patient had now presented in July 2021 with similar complaints of pain and swelling over the same site, for 1 year. Our initial clinical diagnosis was a case of recurrent ganglion cyst. Patient also presented with occasional bouts of fever for the past 2 weeks, which made us suspect osteomyelitis as well. Routine blood parameters showed that an elevated ESR and CRP, blood, and urine cultures were negative and magnetic resonance imaging showed features suggestive of osteomyelitis-involvement of capitate and hamate bone. However, to our surprise, intraoperatively, there were no features suggestive of osteomyelitis and the lesion was excised in-toto and the gross specimen resembled a classic ganglion cyst, which was sent for histopathological examination. To our surprise yet again, it was reported as a case of Giant cell tumor of the tendon sheath, which in retrospect, clinically and radiologically correlated with an intra-osseous involvement of the capitate and hamate. The patient is on regular follow-up to pick up any further recurrences. Conclusion: "Once a ganglion, always a ganglion" should not be taken as the Gospel truth. Histopathological diagnosis continues to remain as the gold standard, especially in cases of soft-tissue swellings of the hand. Correlation and integration of clinical features, Imaging modalities and histopathological diagnosis are the cornerstone in the management of GCTTS.

12.
JAAD Case Rep ; 14: 46-48, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34258351
13.
Insights Imaging ; 12(1): 98, 2021 Jul 13.
Article in English | MEDLINE | ID: mdl-34255196

ABSTRACT

OBJECTIVES: To review the clinical and imaging data of spinal giant cell tumour of the tendon sheath (GCTTS) to improve our understanding of the disease. METHODS: The imaging findings, clinicopathological features and clinical outcomes of 14 patients with pathologically confirmed spinal GCTTS were analysed retrospectively. RESULTS: All 14 patients had a single spinal lesion, including ten cervical vertebra lesions and four thoracic vertebra lesions. CT scan findings: The lesions showed osteolytic bone destruction and were centred on the facet joint, eroding the surrounding bone with a paravertebral soft tissue mass. MRI scan findings: all the lesions manifested predominantly as isointense or hypointense on T1-weighted imaging (T1WI). On T2-weighted imaging (T2WI), eight lesions were hypointense, and four were isointense. The remaining two lesions showed slight hyperintensity. The enhanced scans of eight lesions showed moderate to marked homogeneous or heterogeneous enhancement. PET/CT findings: Among the five patients who underwent PET/CT, three presented lesions with well-defined, sclerotic borders, and the uptake of 18F-FDG was markedly increased. One lesion showed an ill-defined border and an uneven increase in 18F-FDG uptake with an SUVmax value of 8.9. A recurrent lesion was only found on PET/CT 45 months after surgery and the SUVmax was 5.1. CONCLUSIONS: Spinal GCTTS is extremely rare. Osteolytic bone destruction in the area of the facet joint with a soft tissue mass and hypointensity on T2WI images are indicative of the spinal GCTTS. GCTTS shows high uptake of 18F-FDG, and PET/CT is helpful in detecting recurrent lesions.

14.
Arch. méd. Camaguey ; 25(2): e6896, mar.-abr. 2021. tab, graf
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1248832

ABSTRACT

Fundamento: el tumor de células gigantes de la vaina tendinosa ocupa el segundo lugar en frecuencia dentro de las neoplasias de la mano. El diagnóstico es clínico y radiológico y se confirma por medios de estudios anatomopatológicos. Objetivo: describir la epidemiología, aspectos clínicos e histológicos del tumor de células gigantes de la vaina tendinosa. Métodos: se realizó un estudio observacional descriptivo para el reporte de seis casos de los archivos del Departamento de Anatomía Patológica de 2016 y 2018, para identificar los casos con diagnóstico tumor de células gigantes de la vaina tendinosa. Resultados: se diagnosticaron un total de seis casos de tumor de células gigantes de la vaina tendinosa, los cuales se correspondieron a igual número de casos para cada sexo, en su mayoría eran pacientes menores de 40 años y en todos los casos el sitio de presentación del tumor fue la mano, con predominio de la región palmar del dedo pulgar. Ninguno de los casos manifestó dolor. En el estudio morfológico microscópico se observaron, los elementos histológicos característicos del tumor de células gigantes de la vaina tendinosa. Conclusiones: los seis pacientes estudiados presentaron la clínica típica del tumor de células gigantes de vaina tendinosa, es decir, refirieron aumento de volumen que se corroboró con el examen físico al palpar una tumoración de tejido subcutáneo, no dolorosa, lisa, blanda y de bordes bien definidos. De igual manera en el estudio histopatológico, se corroboraron los elementos morfológicos característicos, por lo cual se puede establecer que hubo una correlación clínico-patológica del 100 %.


ABSTRACT Background: the giant cell tumor of the tendon sheath occupies the second place in frequency in the neoplasms of the hand. The diagnosis is clinical and radiological, confirmed by anatomic-pathological studies. Objective: to describe the epidemiology, clinical and histological aspects of the giant cell tumor of the tendon sheath. Methods: a descriptive observational study was carried out for the report of six cases from the files of the Department of Pathology from 2016 and 2018, to identify the cases with a diagnosis of giant cell tumor of the tendon sheath. Results: a total of six cases of giant cell tumor of the tendon sheath were diagnosed, corresponding 50% to each sex; the majority were under 40 years old; and in all cases the site of presentation of the tumor was the hand; with a predominance in the palm region of the thumb. None of the cases manifested pain. In the morphological study, the characteristic histological elements of the giant cell tumor of the tendon sheath were observed microscopically. Conclusions: the six patients studied presented the typical symptoms of the Giant cell tumor of the tendon sheath, referring to an increase in volume that was corroborated with the physical examination by palpating a mass of subcutaneous, non-painful, smooth, soft tissue with well-defined borders. In the same way, histopathologically, the characteristic morphological elements were corroborated, for which it can be established that there was a clinical-pathological correlation of 100%.

15.
Oman Med J ; 36(1): e227, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33692909

ABSTRACT

Tenosynovial giant cell tumor (TGCT) is a benign soft-tissue neoplasm that rarely occurs in the craniofacial region. We report a case of a 27-year-old male who presented to our unit in September 2017 with severe temporomandibular joint (TMJ) pain and progressive limitation opening his mouth. Based on clinical and imaging examinations, a well-defined soft tissue lesion was identified within the right infratemporal fossa, causing pressure on the TMJ and the surrounding structures. The lesion was surgically excised through trans-mandibular and endoscopic approaches. Histopathology diagnosis revealed a rare chondroid subset of TGCT. At 18 months follow-up, the patient showed resolution of the jaw pain, good functional and esthetic outcomes, and no evidence of recurrence.

16.
J Foot Ankle Surg ; 60(1): 163-166, 2021.
Article in English | MEDLINE | ID: mdl-33162292

ABSTRACT

Giant cell tumor of the tendon sheath is a slowly growing benign tumor. It usually arises from the tendon sheath and periarticular soft tissue of small joints. However, it may infrequently involve the large joints emerging around the knee, elbow, and hip joints. Giant cell tumor of the tibialis tendon sheath is rarely reported in the foot and ankle joint. Here, we report the first case in the medical literature of bilateral mirror-symmetrical giant cell tumor of the tendon sheath in the foot and ankle. A 12-year-old male presented with a bilateral and mirror-image mass on his ankles extending to the foot. It was painless but affected his gait and footwear. Staged complete resection was done first on the right then on the left side, with no recurrence after 1 year. The role of genes can be argued for this presentation and giant cell tumor's etiology, owing to the bilateralism and mirror-image presentation. Studies are needed to explore this genetic aspect and its role in management.


Subject(s)
Ankle , Giant Cell Tumors , Ankle Joint/diagnostic imaging , Ankle Joint/surgery , Child , Giant Cell Tumors/diagnostic imaging , Giant Cell Tumors/surgery , Humans , Male , Neoplasm Recurrence, Local , Tendons/diagnostic imaging , Tendons/surgery
17.
Ciênc. rural (Online) ; 51(11): e2000786, 2021. graf
Article in English | LILACS-Express | LILACS, VETINDEX | ID: biblio-1278879

ABSTRACT

ABSTRACT: A 12-year-old female mixed-breed dog presented with lameness, pain, and an enlarged, non-ulcerated, nodular mass in the region proximal to the tarsal joint of the right pelvic limb. Surgical excision was performed, revealing a 6.5 cm mass adherent to the deep flexor tendon and adjacent tissues. The cut section had cysts filled with blackened clotted material, which exuded reddish serous fluid. Microscopically, the cysts were filled with red blood cells and were either denuded or covered by synoviocytes. In addition, the mass was characterized by marked fibrovascular connective tissue associated with siderophages and multinucleated giant cells. These findings were consistent with those of pigmented villonodular tenosynovitis, a rare condition affecting several animal species and humans.


RESUMO: Uma cadela de 12 anos, sem raça definida, apresentou claudicação, algia e aumento de volume não ulcerado, de aspecto nodular, na região proximal à articulação do tarso do membro pélvico direito. A excisão cirúrgica foi optada e revelou uma massa de 6,5 cm de diâmetro, aderida ao tendão flexor profundo e aos tecidos adjacentes. Ao corte, exsudava líquido seroso avermelhado e cistos preenchidos por material coagulado enegrecido foram observados. Microscopicamente, a massa apresentava formações císticas frequentemente preenchidas por hemácias, que encontravam-se ora revestidas por sinoviócitos, ora desnudas. Havia ainda acentuada quantidade de tecido fibrovascular associado a siderófagos e células gigantes multinucleadas. Esses achados foram consistentes com tenossinovite vilonodular pigmentada, uma rara condição que afeta diversas espécies de animais e humanos.

18.
J Hand Microsurg ; 12(Suppl 1): S50-S53, 2020 Oct.
Article in English | MEDLINE | ID: mdl-33335372

ABSTRACT

This article describes a rare case of giant cell tumor of the tendon sheath (GCTTS) that was developed over the substance of chimeric-free latissimus dorsi and -serratus -anterior muscle flaps performed for lower limb reconstruction. To our knowledge, development of GCTTS over a free flap is first described in the literature. A 71-year-old -woman was presented with a large protuberant ulcerated tumor mass that was developed over the substance of chimeric free muscle flaps at the foot and ankle. We performed an extensive tumor resection, and the pathology report confirmed the presence of a primary giant cell tumor. The patient was advised to have a below-knee amputation. However, the patient refused the amputation, and 4 months later, she was presented with a metastatic mass proximally at the upper thigh. We believe that the GCTTS was associated with the chronic inflammation of the soft tissue and bones along with the recurrent episodes of infection, mainly due to proteus mirabilis and proteus syndrome (PS). PS may lead to the development of malformations and overgrowth of different tissues in unusual locations. In cases resistant to antibiotics, the radical surgical debridement should be considered as the most effective treatment.

19.
Ann Med Surg (Lond) ; 58: 143-146, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32983435

ABSTRACT

INTRODUCTION: GCTTS is the second most popular soft tissue tumor at the hand next to ganglion cyst, and also named tenosynovial giant cell tumor or pigmented villonodular tenosynovitis. It is divided into localized form and diffuse form. We introduce a report of a rare case of GCTTS in a female where lesions were identiied within the left ring finger and also conducted a literature review. PRESENTATION OF CASE: We describe a 32-year-old female patient with GCTTS a single digit since six months. Radiographic and histopathological examination is necessary to help determine whether to take further treatment. Surgical excision was performed, including complete removal of the tumor and reconstruction of the pulley with autologous tendon. Histopathology suggested that these masses were consistent with GCTTS without malignancy. There was no clinical and radiologic evidence of recurrence six months after surgery. DISCUSSION: GCTTS is a benign fibrous tissue tumor originating from the tenosynosheath, bursae and joint synovium. This tumor is more common in adults aged 30-50, and is slanted toward females. The major risk of GCTTS is recurrence and joint damage, which requires surgical resection. The integrity of the pulley plays an important role in the function of the hand. In this case, the ipsilateral metacarpal tendon was taken during the operation to reconstruct the pulley to reduce the possibility of loss of hand function. CONCLUSION: This case represents a rare case of GCTTS at the hand within a single digit. Due to its high recurrence rate, the tumor should be completely removed to reduce the possibility of recurrence. Radiographic and histopathological examination must be performed on the tumor, which is determined to be benign and does not require further treatment. The function of the hand should be reconstructed to minimize the loss if necessary.

20.
J Clin Orthop Trauma ; 11(4): 690-693, 2020.
Article in English | MEDLINE | ID: mdl-32684714

ABSTRACT

The giant cell tumor of tendon sheath (GCTTS) or nodular tenosynovitis arises as discrete solitary nodule in the tendon sheath near joints of toes and fingers. Multifocal giant cell tumor of tendon sheath is a rare entity, of which the etiology is not yet fully understood and it is different from diffuse type of GCTTS. Diffuse type of GCTTS occurs around large joints having a main mass from which a small satellite nodule may arise. Multifocal GCTTS along a single tendon is a more rare entity. Herein, we describe a case of multifocal GCTTS along the tendon sheath of flexor digitorum profundus tendon of index finger. The patient was managed by surgical excision of the tumor swellings with no recurrence at two years follow up.

SELECTION OF CITATIONS
SEARCH DETAIL
...